Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.6
Journals
Biology
Special Issues
Vav Proteins: Key Signaling Players in Health and Disease
share announcement

Vav Proteins: Key Signaling Players in Health and Disease

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Cancer Biology".

Deadline for manuscript submissions: closed (1 August 2021) | Viewed by 7107

Special Issue Editors

Prof. Dr. Shulamit Katzav

E-Mail Website
Guest Editor
Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem, Jerusalem 9112102, Israel
Interests: Vav1, an oncogene and a signal transducer protein
Prof. Dr. Xose R. Bustelo

E-Mail Website
Guest Editor
Centro de Investigación del Cáncer-Cancer Research Center, CSIC-University of Salamanca, Campus Unamuno s/n, E-37007 Salamanca, Spain
Interests: identification of early oncogenic drivers; molecular coadjutants; pathobiological programs involved in cancer development and progression

Special Issue Information

Dear Colleagues,

This Special Edition will provide an in-depth scope of the Vav proteins. These proteins play cardinal regulator roles as signal transducers in various physiological systems. Due to their important functions, their dysfunction leads to the emergence of various diseases, such as cancer. This Special Edition will follow the discovery of this unique family of proteins, their functions, and their involvement in health and disease.

Prof. Dr. Shulamit Katzav
Prof. Dr. Xose R. Bustelo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Vav
  • GEF 
  • Rho/RacGTPases 
  • Immunology 
  • Cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

11 pages, 941 KiB  
Review
VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
by Myriam Cuadrado and Javier Robles-Valero
Biology 2021, 10(9), 888; https://doi.org/10.3390/biology10090888 - 8 Sep 2021
Cited by 8 | Viewed by 3182
Abstract
Guanosine nucleotide exchange factors (GEFs) are responsible for catalyzing the transition of small GTPases from the inactive (GDP-bound) to the active (GTP-bound) states. RHO GEFs, including VAV proteins, play essential signaling roles in a wide variety of fundamental cellular processes and in human [...] Read more.
Guanosine nucleotide exchange factors (GEFs) are responsible for catalyzing the transition of small GTPases from the inactive (GDP-bound) to the active (GTP-bound) states. RHO GEFs, including VAV proteins, play essential signaling roles in a wide variety of fundamental cellular processes and in human diseases. Although the most widespread archetype in the field is that RHO GEFs exert proactive functions in cancer, recent studies in mice and humans are providing new insights into the in vivo function of these proteins in cancer. These results suggest a more complex scenario where the role of GEFs is not so clearly defined. For example, VAV1 can unexpectedly play non-catalytic tumor suppressor functions in T-cell acute lymphoblastic leukemia (T-ALL) by controlling the levels of the active form of NOTCH1 (ICN1). This review focuses on emerging work unveiling tumor suppressor roles for these proteins that should prompt a reevaluation of the role of VAV GEF family in tumor biology. Full article
(This article belongs to the Special Issue Vav Proteins: Key Signaling Players in Health and Disease)
►▼ Show Figures

Figure 1

14 pages, 1532 KiB  
Review
New Functions of Vav Family Proteins in Cardiovascular Biology, Skeletal Muscle, and the Nervous System
by Sonia Rodríguez-Fdez, L. Francisco Lorenzo-Martín, Salvatore Fabbiano, Mauricio Menacho-Márquez, Vincent Sauzeau, Mercedes Dosil and Xosé R. Bustelo
Biology 2021, 10(9), 857; https://doi.org/10.3390/biology10090857 - 1 Sep 2021
Cited by 9 | Viewed by 3338
Abstract
Vav proteins act as tyrosine phosphorylation-regulated guanosine nucleotide exchange factors for Rho GTPases and as molecular scaffolds. In mammals, this family of signaling proteins is composed of three members (Vav1, Vav2, Vav3) that work downstream of protein tyrosine kinases in a wide variety [...] Read more.
Vav proteins act as tyrosine phosphorylation-regulated guanosine nucleotide exchange factors for Rho GTPases and as molecular scaffolds. In mammals, this family of signaling proteins is composed of three members (Vav1, Vav2, Vav3) that work downstream of protein tyrosine kinases in a wide variety of cellular processes. Recent work with genetically modified mouse models has revealed that these proteins play key signaling roles in vascular smooth and skeletal muscle cells, specific neuronal subtypes, and glia cells. These functions, in turn, ensure the proper regulation of blood pressure levels, skeletal muscle mass, axonal wiring, and fiber myelination events as well as systemic metabolic balance. The study of these mice has also led to the discovery of new physiological interconnection among tissues that contribute to the ontogeny and progression of different pathologies such as, for example, hypertension, cardiovascular disease, and metabolic syndrome. Here, we provide an integrated view of all these new Vav family-dependent signaling and physiological functions. Full article
(This article belongs to the Special Issue Vav Proteins: Key Signaling Players in Health and Disease)
►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop